Related Experiment Video

Updated: Apr 25, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

11.4K

Update in the management of allergic fungal sinusitis

Osama Marglani1

  • 1Department of Otolaryngology, Head & Neck Surgery, College of Medicine, Umm Al-Qura University, and King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia. E-mail. marglani1@yahoo.com.

Saudi Medical Journal
|August 18, 2014
PubMed

Insights

Allergic fungal sinusitis (AFS) is a distinct chronic rhinosinusitis. This review examines current surgical and medical treatments for AFS, highlighting the need for coordinated care despite high recurrence rates.

Area of Science:

  • Otolaryngology
  • Allergy Immunology

Background:

  • Allergic fungal sinusitis (AFS) is a distinct clinical and pathological entity within chronic rhinosinusitis.
  • The exact etiology, pathogenesis, and natural history of AFS remain incompletely understood.
  • Optimal treatment strategies for AFS are currently debated among clinicians.

Purpose of the Study:

  • To review current literature on surgical and non-surgical treatment options for Allergic Fungal Sinusitis.
  • To consolidate data on the management of AFS, including medical and surgical interventions.
  • To provide an overview of therapeutic approaches for AFS.

Main Methods:

  • Literature review of current data and studies on Allergic Fungal Sinusitis.
  • Analysis of various surgical techniques and medical treatment modalities for AFS.
  • Examination of treatment outcomes and recurrence rates in AFS management.

Main Results:

  • Management of AFS typically involves a multimodal approach.
  • Treatment includes functional endoscopic sinus surgery combined with systemic and local steroids, and allergic immunotherapy.
  • Despite aggressive interventions, high recurrence rates are frequently reported in AFS patients.

Conclusions:

  • Effective management of AFS requires a coordinated approach between surgeons and physicians.
  • Further research is needed to fully understand AFS and optimize treatment strategies.
  • Addressing the high recurrence rates remains a significant challenge in AFS management.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

12.7K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.5K

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
653
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
114
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K